Madrigal Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-157.6M | $-157.9M | $334.0K | $20.7M |
| FY2021 | $-183.9M | $-184.1M | $209.0K | $26.9M |
| FY2022 | $-224.9M | $-225.1M | $217.0K | $31.6M |
| FY2023 | $-324.2M | $-325.7M | $1.5M | $49.7M |
| FY2024 | $-455.6M | $-457.0M | $1.5M | $79.9M |